Boyden Executive Monitor Finds Building Cybersecurity Teams a Priority as Data Breaches Soar
NEW YORK and LONDON, 2015-11-30 11:25 CET (GLOBE NEWSWIRE) -- Demand for cybersecurity executives is dramatically increasing as cyberattacks have grown and boards and company leadership sharpen their focus on data security, according to the quarterly Executive Monitor released today byBoyden Global Executive Search.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/e0be9bbf-ec0a-4b0a-8e84-c35cdcdec54e
“Organizations are intensively seeking senior cyber talent, though they are having a difficult time finding the right candidates,” said Tim McNamara, Managing Partner, Boyden Washington D.C. and Co-Founder of the firm’s Risk Management & Security sector. “It’s a very complicated sector with bifurcated responsibilities. Consequently, there are multiple strategies to address cybersecurity needs among the commercial, military and defense, and intelligence segments.”
The report covers the rise in Chief Information Security Officer (CISO) and Chief Security Officer (CSO) hiring, the clout of these roles within the executive suite, the need for a balance of technical and management skills, the debate over individual privacy versus collective security, and the mounting risk to corporate and government organizations. The Executive Monitor also includes industry-specific sections on financial services, healthcare and consumer/retail.
"Now more than ever before, because so many high-profile companies have suffered severe security breaches, these critical technical skills are in serious demand to ensure companies are able to save themselves from meltdown,” said Vicky Maxwell Davies, Partner of Boyden UK. “Unfortunately, too many INFOSEC professionals have traditionally come up the audit route and don't combine the tech savvy with the business nous.”
The new report from Boyden also focuses on the following topics affecting cybersecurity and risk management talent acquisition:
- C-suite and board increasing involvement in cybersecurity
- Disconnect between increasing responsibility of CISOs and CSOs versus decision-making authority
- Breaches and cost to corporate reputation
- Cooperation among competitor companies, particularly in financial services
Growth trajectory of the cybersecurity industry to $170 billion by 2020
“It’s the board’s responsibility to challenge management to understand the strategic and systematic nature of an organization’s cyber risk vulnerability and properly allocate resources for risk management,” explained Richard Fudickar, Managing Partner of Boyden Germany. “It’s also important to create awareness holistically within a company, going beyond IT to include all executives, HR and team members to treat data with the highest level of security. Management must understand that this issue is about people and behaviors, not just technology.”
“There has been a great degree of formal and informal cooperation among the large Canadian financial institutions around cybersecurity issues including the sharing of information and best practices,” added Kevin Gormely, Partner of Boyden Toronto. “There is recognition by these organizations, many of which are direct competitors, that they are all likely to be victims of a cybersecurity breach at one time or another.”
The full Boyden Executive Monitor report is available at www.boyden.com.
About Boyden World Corporation
Boyden is a global leader in retained executive search and talent advisory services with more than 70 offices in over 40 countries. Founded in 1946, Boyden specializes in senior executive search, interim management and human capital consulting across a broad spectrum of markets and sectors. For further information, please visit www.boyden.com.
The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.
Contacts: Dan Margolis, for Boyden t. +1 (213) 452.6472 e. firstname.lastname@example.org Kara Condon, for Boyden t. email@example.com e. +32 (0)2 289.09.49
Om NASDAQ OMX
NASDAQ OMX (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra NASDAQ OMX
Registrer deg med din epostadresse under for å få de nyeste sakene fra NASDAQ OMX på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra NASDAQ OMX
XBiotech Announces First Patient in Study Evaluating MABp1 in Combination with Onivyde® and 5-fluorouracil/folinic acid for the Treatment of Pancreatic Cancer18.10.2017 16:53 | Pressemelding
AUSTIN, Texas, Oct. 18, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today enrollment of the first patient into a Phase I single arm study evaluating the maximum tolerated dose of Onivyde® (Irinotecan liposome injection) and 5-fluorouracil/folinic acid in combination with MABp1 in a cohort of patients with advanced pancreatic adenocarcinoma and cachexia. The patient has begun treatment at Cedars-Sinai Medical Center under the care of Dr. Andrew Hendifar, the Study's Principle Investigator, Medical Oncology lead for the Gastrointestinal Disease Research Group and Co-Director of Pancreas Oncology at Cedars-Sinai. A total of 16 patients are expected to be enrolled in the study. Dr. Hendifar commented, "We are excited to enroll our first patient in this novel combinatorial therapy for the treatment of advanced pancreatic cancer and cachexia. This is the first attempt to add an anti-inflammatory therapy to standard chemotherapy in an effort to improve the performanc
Nasdaq and SGX Establish Collaborative Listings Agreement18.10.2017 15:42 | Pressemelding
NEW YORK and SINGAPORE, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Nasdaq Inc. (Nasdaq:NDAQ) and Singapore Exchange (SGX) today announced the signing of a collaborative agreement in a move to leverage their strengths as two of the leading listings venues in the U.S. and Asia respectively. The new agreement seeks to enhance the channels available for companies to access capital market funding and enhance their corporate profile in both markets. As part of this agreement, Nasdaq and SGX -- who also share a successful, long-term market technology relationship -- are currently exploring the demand among corporates for a concurrent or sequential listing on both exchanges. Nasdaq and SGX are committed to supporting companies that are interested in pursuing this route. "The business landscape today is borderless," said Loh Boon Chye, CEO, SGX. "Fast-growing Asian companies looking to tap the capital markets can choose to list on SGX on Asian home ground, and embark on a listing on Nasdaq
Colliers International Expands in Washington, D.C.18.10.2017 14:30 | Pressemelding
Acquisition of Beltway Real Estate Services Firm Strengthens Ongoing Commitment to the Region TORONTO and WASHINGTON, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Leading global commercial real estate services firm Colliers International Group Inc. (NASDAQ:CIGI)(TSX:CIGI) announced today the acquisition of leading tenant representation advisory firm Serten Advisors. With its office in Tysons Corner, the firm serves global, national, and regional clients with a highly skilled and experienced team of professionals that have more than 100 years of combined experience. "This strategic acquisition positions Colliers to gain additional market share and win new business in the vibrant and competitive Suburban DC markets," said Marty Pupil, Colliers International President | U.S. Brokerage. "Adding Steve and Paul and the rest of their talented leadership team to our existing group of professionals in the region will further position Colliers as the commercial real estate services firm of
InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting® in Washington, DC18.10.2017 14:00 | Pressemelding
InSphero AG / InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting® in Washington, DC . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. New 3D InSight(TM) Human Liver Fibrosis Model represents a powerful tool for screening efficacy and safety of anti-fibrotic drugs in vitro. Schlieren, Switzerland, Oct. 18, 2017 (GLOBE NEWSWIRE) -- InSphero AG, the leading supplier of assay-ready 3D cell culture models for accelerating drug discovery and development, will present data characterizing and demonstrating the utility of its new 3D InSight(TM) Human Liver Fibrosis Model for screening efficacy of anti-fibrotic drugs. The findings will be presented at oral and poster presentations this Friday at the annual meeting of the American Association for the Study of Liver Disease (AASLD) Conference in Washington, DC. Anti-fibrotic therapi
Kofax Wins "Most Innovative Solution for Banking Customer Authentication" Award for Third Consecutive Year18.10.2017 08:00 | Pressemelding
Grand Prix Banque & Innovation Honor Recognizes Kofax Mobile ID Customer Onboarding Solution and its Anti-Fraud Capabilities IRVINE, Calif., Oct. 18, 2017 (GLOBE NEWSWIRE) -- Kofax ®, a leading provider of software to simplify and transform the First Mile(TM) of business, today announced that Kofax Mobile ID(TM) has won "Most Innovative Solution for Banking Customer Authentication" in the 2017 Grand Prix Banque & Innovation Awards in Paris, France. Now in its fourth year, the Awards identify excellence and innovation in the banking sector. The program acknowledges technology companies that have launched and implemented the most outstanding banking-related software solutions, initiatives and projects in France over the past twelve months. This award highlights the new facial recognition and ID verificationfeatures of Kofax Mobile ID that determine the authenticity and validity of identification documents and their holders.
World Conference on Lung Cancer Wednesday Press Conference: PD-1/PD-L1 Advancements and Interventions to Prevent and Treat Lung Cancer18.10.2017 06:25 | Pressemelding
YOKOHAMA, Japan, Oct. 18, 2017 (GLOBE NEWSWIRE) -- The final press conference from the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC) highlighted new advancements surrounding the discovery of PD-1 and PD-L1, including a discussion from the researcher credited with discovering PD-1, as well as interventions to prevent lung cancer and improve quality of life for lung cancer patients. Innovations in lung cancer treatment linked to the discovery of PD-1 Prof. Tasuku Honjo of Japan, who was the first to identify PD-1 in 1992, shared an update on how PD-1 blockers have been widely used to treat many types of cancers. After decades of study, research into PD-1 has led to breakthrough immunotherapy treatments that are being hailed as a "penicillin moment" in cancer treatment. "I believe that, just as a number of antibiotics developed in the wake of the discovery of penicillin now p
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom